From potential blockbuster to zilch in about 6 mths. Without Wyeth's marketing power and a nonapprovable letter requiring a second positive maintenance study in schizophrenia, bifeprunox is as good as dead.
Saturday, March 1, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment